Early Access Press release

Inceptua

  • Inceptua
  • Posted by Inceptua
05/10/2021
4 min read

Inceptua strengthens early access division with key business development hire

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Read More
  • Inceptua
  • Posted by Inceptua
14/01/2021
5 min read

Is there a role for Ethics Committees in Early Access?

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Read More
  • Inceptua
  • Posted by Inceptua
28/12/2020
2 min read

Elevar Therapeutics Inc. Announces Licensing Agreement with Inceptua Group

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Read More
  • Inceptua
  • Posted by Inceptua
10/12/2020
7 min read

Inceptua Q&A: What is Early Access?

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Read More
  • Inceptua
  • Posted by Inceptua
03/12/2020
4 min read

Inceptua Partners with Global Blood Therapeutics for an Early Access Program for Voxelotor for Patients with Sickle Cell Disease

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Read More
  • Inceptua
  • Posted by Inceptua
06/11/2020
2 min read

Early Access regulatory update 2020

Regulatory Update 2020 The regulations governing pre-approval access...

Read More
  • Inceptua
  • Posted by Inceptua
02/11/2020
3 min read

Maintaining access to your medicines during COVID19

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Read More
  • Inceptua
  • Posted by Inceptua
07/10/2020
6 min read

Helping get orphan drugs to patients quicker

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Read More
  • Inceptua
  • Posted by Inceptua
25/09/2020
4 min read

Inceptua receives approval of marketing authorization transfer of Jetrea® (ocriplasmin) for the treatment of symptomatic vitreomacular adhesion

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Read More
  • Inceptua
  • Posted by Inceptua
26/06/2020
4 min read

Inceptua Group Announces Partnership with BioCryst on Expanded Access Program for Patients with Hereditary Angioedema

Inceptua Group Announces Partnership with BioCryst on Expanded...

Read More
You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

CONTINUE